# US 2026/0193664 A1 · Methods and compositions for the modification of plants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0193664 A1
- Document ID: US20260193664A1
- Status: Published application
- Kind: A1
- Application number: 19/303,663
- Filed: 2025-08-19
- Published: 2026-07-09
- Earliest claimed: 2018-08-24
- Assignees: Flagship Pioneering Innovations VI, LLC
- Applicants: Flagship Pioneering Innovations VI, LLC
- Inventors: Maria Helena Christine VAN ROOIJEN; Hok Hei TAM; Maier Steve AVENDANO AMADO; Barry Andrew MARTIN; Ignacio MARTINEZ; Piotr Stanislaw KOWALSKI; Nataliya Vladimirovna NUKOLOVA; Yajie NIU
- Web page: https://patentgrep.com/patent/US20260193664A1

## CPC

- C12N 15/8213: {Targeted insertion of genes into the plant genome by homologous recombination}
- C12N 15/8206: {by physical or chemical, i.e. non-biological, means, e.g. electroporation, PEG mediated}
- C12N 15/8218: {Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]}
- C12N 15/827: {Flower development or morphology, e.g. flowering promoting factor [FPF]}
- C12N 15/87: Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N 15/90: Stable introduction of foreign DNA into chromosome
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Disclosed herein are plant-modifying compositions including a plurality of plant messenger packs (PMPs) (e.g., including a plant extracellular vesicle (EV), or segment, portion, or extract thereof), wherein the PMPs include a plant-modifying agent, and wherein the plant-modifying agent comprising the heterologous RNA. The compositions herein are useful in methods for modifying plants such as to increase plant fitness, wherein the increase in plant fitness comprising an increase in development, growth, yield, resistance to abiotic stressors, or resistance to biotic stressors.

## Claims

### Claim at position 1

1-17. (canceled)

### Claim 18

A method of modulating expression of a target gene in a plant, the method comprising: contacting the plant with a composition comprising a plurality of plant-derived lipid particles, wherein each plant-derived lipid particle comprises:
a. a heterologous plant-modifying polynucleotide; and
b. lipids extracted from one or more plant sources and reconstituted into a vesicular structure;
wherein:
i. the heterologous plant-modifying polynucleotide modulates expression of a target gene in the plant; and
ii. contacting the plant with the composition alters expression of the target gene of the plant relative to an untreated plant.

### Claim 19 (depends on 18)

The method of claim 18, wherein the heterologous plant-modifying polynucleotide is selected from mRNA, a guide RNA (gRNA), a siRNA, a shRNA, a miRNA, a plasmid, or a DNA molecule encoding any of the foregoing.

### Claim 20 (depends on 18)

The method of claim 18, wherein each plant-derived lipid particle further comprises an exogenous cationic lipid.

### Claim 21 (depends on 20)

The method of claim 20, wherein the exogenous cationic lipid is present at 1-90% of total lipid content of the plant-derived lipid particle.

### Claim 22 (depends on 20)

The method of claim 20, wherein the exogenous cationic lipid is dioleoyl-3-trimethylammonium propane (DOTAP) or DC-cholesterol.

### Claim 23 (depends on 22)

The method of claim 22, wherein DOTAP comprises between 25-40% of total lipids in the plant-derived lipid particle.

### Claim 24 (depends on 22)

The method of claim 22, wherein DC-cholesterol comprises between 20-40% of total lipids in the plant-derived lipid particle.

### Claim 25 (depends on 20)

The method of claim 20, wherein the plant-derived lipid particles have a zeta potential greater than −20 mV.

### Claim 26 (depends on 18)

The method of claim 18, wherein each plant-derived lipid particle further comprises one or more plant extracellular vesicle marker proteins.

### Claim 27 (depends on 18)

The method of claim 18, wherein the plant derived particles have a median size of between 89 to 104 nm.
